Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions


Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Productivity Commission Draft Report on Intellectual Property Arrangements

Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property (IP) arrangements. While the 400 page draft has only just been made available, we do have a number of concerns with the interim-findings which we believe may inadvertently lead to public misunderstanding of patents and IP as it…

View article· Friday, 29 April 2016

World Intellectual Property Day 2016

Medicines Australia acknowledges World Intellectual Property Day, an international initiative celebrating the role intellectual property plays in stimulating innovation. Medicines Australia represents the research-based innovative medicines industry in Australia. Our members invest more than $1 billion every year in Australian-based research and development such as clinical trials and partnerships with Australian Universities, Biotechs and research…

View article· Wednesday, 27 April 2016

Less red tape for Clinical Trials will benefit patients and researchers

Medicines Australia welcomes the announcement made by the nation’s Health Ministers in Perth to work towards a national framework for clinical trials. A new commitment was made by the COAG health council to identify more ways we can improve Australia’s attractiveness as a preferred destination for clinical trials. This type of reform is exactly what…

View article· Monday, 11 April 2016

Joint Media Release: Medicines sector reforms deliver consumer benefits and a sustainable PBS

Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April. The direct contribution the medicine supply chain is making to these savings will ensure the PBS is sustainable into the future, enabling the reinvestment savings into the funding of new, breakthrough medicines for Australian…

View article· Monday, 4 April 2016

Pat Clear Award Winner 2016

The 2016 Pat Clear Award, has been won by Ms Zarli French, Senior Manager External Affairs at MSD. This prestigious award is presented annually to recognise outstanding contributions by those who work in the Australian medicines industry. Ms French has been working at MSD for 30 years. She is well known for her outstanding achievements…

View article· Friday, 1 April 2016

Interim CEO Appointed to Medicines Australia

The Board of Medicines Australia has appointed Mr Lee Hill to the role of Interim CEO. Mr Hill joins Medicines Australia with over 10 years of experience as a senior business leader, having held CEO and Managing Director roles in a number of leading companies and consultancies across Australia. Mr Wes Cook, Chair of Medicines…

View article· Thursday, 14 January 2016

Medicines Australia CEO

Medicines Australia CEO Tim James today announced his resignation effective January 2016 from the leadership role of the pharmaceutical sector peak body. Medicines Australia Interim Chairman Wes Cook thanked Tim for his strong contribution to the Australian medicines industry during a very difficult period for the sector: “Tim has been a passionate advocate for the…

View article· Saturday, 19 December 2015

Innovation focus will deliver benefits to Australia

Medicines Australia welcomes the Turnbull Government’s National Innovation and Science Agenda and its recognition that innovation is a key to economic growth. The growing policy focus on innovation from all sides of politics is positive news not only for the Australian economy, but ultimately the livelihoods and health of all Australians. Medicines Australia CEO Tim…

View article· Monday, 7 December 2015

PBS medicines save $7 Billion in Hospital Costs

A new report has found that investing in new medicines pays for itself by reducing other public health expenditure. The modelling, published in The impact of pharmaceutical innovation on premature mortality, hospital separations, and cancer survival in Australia, was conducted by American economist Professor Frank Lichtenberg. Medicines Australia CEO Tim James said, “This comprehensive study…

View article· Tuesday, 24 November 2015

Patient Medicine Records Should Be Included In eHealth Data

Medicines Australia has called on the Federal Government to make a patient’s medication records a mandatory inclusion in eHealth profiles to improve the safe use of medicines. The option has been put in a submission to the Senate inquiry into the Government’s eHealth legislation which seeks to make changes to the Personally Controlled Electronic Health…

View article· Thursday, 5 November 2015

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Productivity Commission Draft Report on Intellectual Property Arrangements

World Intellectual Property Day 2016

Innovative medicines industry creates 14000 direct local jobs + supports thousands more inc. thru $1bn of R&D investment in Aust. #auspol

Less red tape for Clinical Trials will benefit patients and researchers

Joint Media Release: Medicines sector reforms deliver consumer benefits and a sustainable PBS

Medicines Aust. is proud of our Code of Conduct which is a standard-bearer for industry self-regulation. Learn more

Congrats @ShannyDyer on appointment as CEO of ARCS: Assoc. For Regulatory & Clinical Scientists. Supporting research of innovative medicine

Disappointing that @ceda_news report on balancing Budget calls for #PBS cuts based on inaccurate, outdated data. #npc #auspol #BudgetRepair

Big thanks @deborah_knight for a wonderful job as MC for the MA Dinner, incl. our expert panel on Aus #innovation.

Was great to have @RichardDiNatale talk at MA Dinner about Aus strengths in clinical trials and medical research.

Thanks @SenKimCarr for speaking at MA Dinner. A strong focus on importance of policy stability inc. R&D incentives.

Thanks Health Min @sussanley for speaking at MA Dinner last night celebrating Aus innovation in biopharmaceuticals.

Health Min @sussanley and our innovation panel Sue MacLeman, MTPConnect; Prof. Maree Smith, UQ; Kathy Connell, J&J

Thanks to all who attended @MedicinesAus dinner at Parliament. Celebrating Aus innovation in biopharmaceuticals.